Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp

Bullboard Posts

Comment by PoorOpinionon Jun 29, 2018 9:32am

60 Views

Post# 28250253

RE:Gotta HURT management's ego

Anybody think there arent going to be growing pains for a market that hoes from zero to billions?

lou64 wrote:
2018-06-29 08:44 ET - In the News

The Globe and Mail reports in its Friday edition that after Canopy Growth's ($40.51) fourth quarter earnings fell "well below" the Street's expectations, AltaCorp Capital analyst Keith Carpenter downgraded the shares to "sector perform" from "speculative buy." The Globe's David Leeder writes that Mr. Carpenter shaved his share target to $40 from $41, $3.93 below the consensus. Mr. Carpenter says in a note: "[Canopy's] size, capacity, inventory levels, and platform all provide the basis in which to grow their business and strengthen their market share. However, one of the issues the Company will have to prove out to investors post the launch of the recreational market is whether they will be efficient with regards to their costs. We accept that management needs to build out its platform and there is a ramp in costs associated with that. However, having never gone through this process in this sector at this level, it's also difficult for management to pinpoint that the substantial ramp that is occurring in SG&A costs will not overshoot and impact those expanded sales later this year and going forward. As a result, we remain cautious of the Company's cost efficiency potential over the next few years."